GO:0006809 nitric oxide biosynthetic process: Biochemistry, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006809 nitric oxide biosynthetic process describes the chemical reactions and pathways that produce nitric oxide (NO), a colorless, slightly water-soluble gas.
• NO is generated from L-arginine by nitric oxide synthase (NOS) enzymes, with NOS1, NOS2, and NOS3 being the principal mammalian isoforms.
• NO functions as a signaling molecule in the cardiovascular, nervous, and immune systems, and its dysregulation is linked to numerous diseases.
• The process is regulated at transcriptional, post-transcriptional, and post-translational levels, including by calcium/calmodulin and phosphorylation.
• NO can modify proteins via S-nitrosylation, affecting cytoskeletal and other cellular functions.
• Experimental models for studying NO biosynthesis include knockout, knock-in, and overexpression cell lines, as well as CRISPR library screening.
Description
Nitric oxide (NO) is a short-lived, gaseous free radical that serves as a critical signaling molecule in diverse physiological processes. The biosynthetic process that generates NO, formally annotated as GO:0006809 nitric oxide biosynthetic process, encompasses the enzymatic and chemical steps leading to NO formation from substrates such as L-arginine. This process is essential for vascular homeostasis, neurotransmission, and immune defense, and its dysregulation contributes to pathologies including cardiovascular disease, neurodegeneration, and cancer. Understanding the molecular players and regulatory mechanisms of NO biosynthesis is therefore of broad biomedical importance. Researchers employ a range of techniques, from genetic knockout models to advanced imaging and omics, to dissect this pathway and its roles in health and disease.
nitric oxide biosynthetic process At A Glance
| GO ID | GO:0006809 |
|---|---|
| GO term | nitric oxide biosynthetic process |
| Ontology | biological_process |
| Synonym | nitric oxide anabolism, nitric oxide biosynthesis, nitric oxide formation, nitric oxide synthesis |
| Major function | Production of nitric oxide (NO), a signaling gas involved in vasodilation, neurotransmission, and immune response |
| Definition | The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. |
| Related enzymes | Nitric oxide synthases (NOS1, NOS2, NOS3) |
| Substrate | L-arginine (for NOS-dependent pathways) |
| Key cofactors | NADPH, FAD, FMN, tetrahydrobiopterin (BH4), calmodulin |
What Is GO:0006809?
GO:0006809 nitric oxide biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. This biological process includes the enzymatic conversion of L-arginine to L-citrulline and NO by nitric oxide synthase enzymes, as well as any alternative routes of NO production. The term is used to annotate gene products that participate in these biosynthetic steps, thereby enabling systematic analysis of NO biology across species.
Why Is nitric oxide biosynthetic process Important in Cell Biology?
Nitric oxide biosynthetic process is fundamental to human physiology because NO acts as a diffusible signal that regulates blood vessel tone, platelet aggregation, immune cell function, and synaptic plasticity. Dysregulated NO production is implicated in a wide spectrum of diseases, including hypertension, atherosclerosis, diabetes, neurodegenerative disorders, and cancer. Moreover, NO can post-translationally modify proteins through S-nitrosylation, influencing cytoskeletal dynamics and other cellular processes. Thus, understanding how NO biosynthesis is controlled offers insights into disease mechanisms and potential therapeutic targets.
• Regulates vascular tone and blood pressure; endothelial NOS (NOS3)-derived NO is essential for vasodilation.
• Mediates neurotransmission and synaptic plasticity in the central and peripheral nervous systems via neuronal NOS (NOS1).
• Plays a key role in immune defense; inducible NOS (NOS2) produces high NO levels to combat pathogens.
• Contributes to pancreatic beta-cell function and dysfunction; NO modulates insulin secretion.
• Involved in redox signaling and oxidative stress; NO interacts with reactive oxygen species.
• Modifies proteins via S-nitrosylation, affecting cytoskeletal organization and other cellular activities.
• Dysregulation is linked to cardiovascular diseases, neurodegeneration, and cancer.
• Serves as a target for pharmacological interventions, including NOS inhibitors and NO donors.
What Happens During nitric oxide biosynthetic process?
Substrate availability and L-arginine uptake
In simple terms: The cell must first obtain the building block L-arginine to make nitric oxide.
Nitric oxide biosynthesis primarily depends on the availability of L-arginine, which is transported into cells or synthesized from citrulline. L-arginine serves as the substrate for nitric oxide synthase (NOS) enzymes. The intracellular concentration of L-arginine can influence the rate of NO production, and arginine transporters and recycling pathways are therefore important regulatory nodes.
NOS enzyme activation and cofactor requirements
In simple terms: NOS enzymes need several helper molecules and calcium to become active.
The NOS enzymes (NOS1, NOS2, NOS3) are homodimeric oxidoreductases that require NADPH, FAD, FMN, tetrahydrobiopterin (BH4), and calmodulin for activity. Calcium/calmodulin binding regulates the constitutive isoforms NOS1 and NOS3, while NOS2 is calcium-independent but transcriptionally induced. Proper assembly of the active dimer and cofactor binding are essential for catalytic function.
Catalytic conversion of L-arginine to NO and L-citrulline
In simple terms: The enzyme NOS converts L-arginine into nitric oxide and citrulline through a two-step oxidation.
NOS catalyzes a two-step oxidation of L-arginine: first to N-hydroxy-L-arginine (NHA), then to L-citrulline and NO. This reaction consumes NADPH and oxygen and requires BH4 as an electron donor. The produced NO can diffuse across membranes and act on nearby targets, including soluble guanylate cyclase, to exert its biological effects.
Post-translational modifications and S-nitrosylation
In simple terms: Nitric oxide can attach to cysteine residues on proteins, changing their function.
NO can covalently modify cysteine thiols in proteins, a process known as S-nitrosylation. This modification can alter protein activity, localization, and interactions, and is involved in regulating cytoskeletal proteins and other cellular components. S-nitrosylation represents a key mechanism by which NO transduces signals beyond its direct effects on guanylate cyclase.
Regulation of NO biosynthesis
In simple terms: The cell controls how much nitric oxide is made by adjusting enzyme levels and activity.
NO biosynthesis is regulated at multiple levels: transcriptional control of NOS genes (e.g., NOS2 induction by cytokines), post-transcriptional modulation by microRNAs, and post-translational modifications such as phosphorylation and S-nitrosylation of NOS enzymes. Additionally, substrate availability, cofactor levels, and interacting proteins (e.g., heat shock protein 90) influence NOS activity. These regulatory layers ensure appropriate NO production in response to physiological demands.
Key Genes Involved in GO:0006809 nitric oxide biosynthetic process
The following genes and proteins are central to nitric oxide biosynthetic process, based on their established roles in NO production and signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOS1 | Neuronal nitric oxide synthase; produces NO in neurons | Neurotransmission, synaptic plasticity, neurodegeneration |
| NOS2 | Inducible nitric oxide synthase; produces high NO levels in immune responses | Inflammation, host defense, cancer |
| NOS3 | Endothelial nitric oxide synthase; produces NO for vascular tone | Cardiovascular disease, hypertension, atherosclerosis |
| GUCY1A1 | Soluble guanylate cyclase subunit; NO receptor | Vasodilation, platelet aggregation |
| GUCY1B1 | Soluble guanylate cyclase subunit; NO receptor | Vasodilation, platelet aggregation |
| ARG1 | Arginase 1; competes with NOS for L-arginine | Regulates NO availability in immune cells |
| ARG2 | Arginase 2; competes with NOS for L-arginine | Regulates NO availability in vascular cells |
| SLC7A1 | Cationic amino acid transporter; L-arginine uptake | Substrate supply for NO synthesis |
| SLC7A2 | Cationic amino acid transporter; L-arginine uptake | Substrate supply for NO synthesis |
| HSP90AA1 | Heat shock protein 90; enhances NOS activity | NOS regulation, cardiovascular protection |
| CALM1 | Calmodulin; activates NOS1 and NOS3 | Calcium-dependent NO signaling |
| AKT1 | Protein kinase B; phosphorylates NOS3 | Endothelial NO production, angiogenesis |
| PARK7 | DJ-1; protects against oxidative stress, may regulate NO | Neurodegeneration, Parkinson's disease |
| NFE2L2 | Nrf2; regulates antioxidant response, influences NO | Redox balance, inflammation |
| TNF | Tumor necrosis factor; induces NOS2 | Inflammation, immune response |
| IL1B | Interleukin-1 beta; induces NOS2 | Inflammation, immune response |
| IFNG | Interferon gamma; induces NOS2 | Immune defense, inflammation |
How Is nitric oxide biosynthetic process Regulated?
Nitric oxide biosynthesis is tightly regulated to meet physiological demands while avoiding toxicity. Constitutive NOS isoforms (NOS1 and NOS3) are activated by calcium/calmodulin binding, whereas inducible NOS2 is primarily regulated at the transcriptional level by cytokines and microbial products. Post-translational modifications, including phosphorylation by AKT1 and other kinases, modulate NOS activity and localization. Additionally, substrate availability (L-arginine) and cofactor (BH4) levels influence NO output, and competitive enzymes such as arginases can limit substrate supply. S-nitrosylation of NOS enzymes themselves can also feedback-regulate their activity.
nitric oxide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOS3 | Hypertension, atherosclerosis | Endothelial cell knockout of NOS3; overexpression of NOS3 |
| NOS2 | Inflammation, cancer, diabetes | Macrophage or beta-cell knockout of NOS2; inducible overexpression |
| NOS1 | Neurodegeneration, stroke | Neuronal knockout of NOS1; point mutation of catalytic residue |
| GUCY1A1 | Cardiovascular disease | Knock-in of patient-associated mutations; knockout in vascular smooth muscle cells |
| ARG1 | Immune regulation, cancer | Knockout in myeloid cells; overexpression in tumor models |
Cardiovascular diseases
Reduced NO bioavailability due to endothelial NOS (NOS3) dysfunction is a hallmark of hypertension, atherosclerosis, and heart failure. NO normally promotes vasodilation and inhibits platelet aggregation and leukocyte adhesion; when NO production is impaired, these protective effects are lost, contributing to vascular pathology. Oxidative stress can uncouple NOS3, leading to superoxide production instead of NO, further exacerbating endothelial dysfunction.
Neurodegenerative disorders
Excessive NO production by neuronal NOS (NOS1) or inducible NOS (NOS2) can mediate neurotoxicity in conditions such as Alzheimer's disease, Parkinson's disease, and stroke. NO can react with superoxide to form peroxynitrite, a potent oxidant that damages neurons. S-nitrosylation of proteins, including parkin and DJ-1, has been implicated in Parkinson's disease pathogenesis.
Cancer
NO plays a dual role in cancer: low concentrations can promote tumor growth and angiogenesis, while high concentrations can induce apoptosis and inhibit tumor progression. NOS2 expression in tumor cells and the tumor microenvironment is associated with chronic inflammation and cancer progression. Targeting NO biosynthesis is being explored as a therapeutic strategy in oncology.
Metabolic disorders
In pancreatic beta cells, NO produced by NOS2 in response to inflammatory cytokines contributes to beta-cell dysfunction and apoptosis, linking NO biosynthesis to type 1 and type 2 diabetes. NO can also modulate insulin signaling and glucose uptake in peripheral tissues.
From nitric oxide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NOS3 affect endothelial NO production? | NOS3 knockout endothelial cell line |
| Does a specific point mutation in NOS2 alter its catalytic activity? | Point-mutation knock-in of NOS2 in macrophages |
| Can overexpression of NOS1 increase NO in neurons? | NOS1 overexpression in neuronal cell line |
| How does tagged NOS3 localize in live cells? | Knock-in of fluorescent tag (e.g., GFP) at NOS3 locus |
| What genes modulate NO biosynthesis in a genome-wide screen? | CRISPR library screening in NO reporter cells |
| Does a disease-associated SNP in GUCY1A1 affect NO signaling? | Knock-in of SNP in vascular smooth muscle cells |
How to Study the nitric oxide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Griess assay | Nitrite/nitrate levels (NO metabolites) | Quantifying NO production in cell culture |
| DAF-FM fluorescence | Intracellular NO | Live-cell imaging of NO dynamics |
| qRT-PCR | mRNA levels of NOS genes | Assessing transcriptional regulation |
| Western blot | Protein expression and phosphorylation | Validating knockout or overexpression |
| Biotin switch assay | S-nitrosylated proteins | Detecting NO-mediated post-translational modifications |
| CRISPR screening | Genes affecting NO production | Genome-wide identification of regulators |
| RNA-seq | Global transcriptome changes | Pathway analysis in NO-related models |
Measuring NO production
Nitric oxide production can be measured using Griess reagent, which detects nitrite (a stable NO metabolite), or by electron paramagnetic resonance (EPR) with spin traps. Fluorescent probes such as DAF-FM can visualize NO in live cells. These methods are essential for validating genetic models of NO biosynthesis.
Gene expression analysis
Quantitative RT-PCR and RNA-seq can quantify mRNA levels of NOS1, NOS2, NOS3, and related genes under different conditions. This helps determine whether changes in NO production are due to transcriptional regulation.
Protein analysis and modifications
Western blotting can assess NOS protein levels and phosphorylation status. S-nitrosylation can be detected using the biotin switch assay or mass spectrometry, revealing post-translational modifications of target proteins.
Functional assays
Vascular reactivity assays, neurotransmission measurements, and immune cell killing assays can evaluate the functional consequences of altered NO biosynthesis. These are often used in conjunction with genetic knockout or knock-in models.
How CRISPR Can Be Used to Study GO:0006809 nitric oxide biosynthetic process
Knockout
CRISPR knockout of NOS1, NOS2, or NOS3 in cell lines or primary cells can abolish specific NO production, allowing researchers to dissect isoform-specific functions. Knockout models are also used to identify compensatory mechanisms and to validate drug targets.
Point Mutation
Introducing point mutations in NOS genes (e.g., in the catalytic domain or phosphorylation sites) via CRISPR can reveal structure-function relationships and mimic disease-associated variants. This approach is valuable for understanding how single amino acid changes affect NO biosynthesis.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or disease-relevant mutations into endogenous NOS loci enables real-time monitoring of expression and function. Knock-in of SNPs in GUCY1A1 or other NO pathway genes can model cardiovascular risk.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase NOS expression to study the effects of enhanced NO production. Overexpression models are useful for investigating NO-mediated signaling and toxicity.
How EDITGENE Supports nitric oxide biosynthetic process Research
Researchers studying nitric oxide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in NO production, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for nitric oxide biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AKT1 Knockout HEK293 Cell Line | EDJ-KQ446 | Human | 207 | Details Get a Quote |
| NOS3 Knockout HEK293 Cell Line | EDJ-KQ840 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout HEK293 Cell Line | EDJ-KQ844 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout HEK293 Cell Line | EDJ-KQ1428 | Human | 4843 | Details Get a Quote |
| CYP1B1 Knockout HEK293 Cell Line | EDJ-KQ2285 | Human | 1545 | Details Get a Quote |
| POR Knockout HEK293 Cell Line | EDJ-KQ3088 | Human | 5447 | Details Get a Quote |
| ARG2 Knockout HEK293 Cell Line | EDC09599 | Human | 384 | Details Get a Quote |
| CYB5R3 Knockout HEK293 Cell Line | EDJ-KQ4440 | Human | 1727 | Details Get a Quote |
| GCH1 Knockout HEK293 Cell Line | EDC07929 | Human | 2643 | Details Get a Quote |
| SPR Knockout HEK293 Cell Line | EDJ-KQ5086 | Human | 6697 | Details Get a Quote |
| SLC7A6 Knockout HEK293 Cell Line | EDJ-KQ6446 | Human | 9057 | Details Get a Quote |
| NOS1AP Knockout HEK293 Cell Line | EDJ-KQ6717 | Human | 9722 | Details Get a Quote |
| CYB5B Knockout HEK293 Cell Line | EDJ-KQ9572 | Human | 80777 | Details Get a Quote |
| MTARC1 Knockout HEK293 Cell Line | EDJ-KQ14327 | Human | 64757 | Details Get a Quote |
| MTARC2 Knockout HEK293 Cell Line | EDJ-KQ14328 | Human | 54996 | Details Get a Quote |
Displaying Records 1 To 15 Of 68 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About nitric oxide biosynthetic process
What is nitric oxide biosynthetic process?
It is the biological process (GO:0006809) by which cells produce nitric oxide (NO) from substrates such as L-arginine, primarily through nitric oxide synthase enzymes.
What genes are involved in nitric oxide biosynthetic process?
Key genes include NOS1, NOS2, and NOS3, which encode neuronal, inducible, and endothelial nitric oxide synthases, respectively.
How is nitric oxide produced in cells?
Nitric oxide is produced when NOS enzymes convert L-arginine to L-citrulline and NO, requiring cofactors like NADPH, FAD, FMN, BH4, and calmodulin.
What is the role of nitric oxide in the body?
NO acts as a signaling molecule that regulates blood vessel dilation, neurotransmission, immune responses, and many other physiological processes.
Which diseases are associated with nitric oxide biosynthesis?
Dysregulated NO production is linked to cardiovascular diseases, neurodegenerative disorders, cancer, and diabetes.
How can I study nitric oxide biosynthesis in the lab?
Common methods include measuring NO metabolites with the Griess assay, imaging with fluorescent probes, and using CRISPR knockout or knock-in cell models.
What are the synonyms for nitric oxide biosynthetic process?
Synonyms include nitric oxide anabolism, nitric oxide biosynthesis, nitric oxide formation, and nitric oxide synthesis.
What is the GO ID for nitric oxide biosynthetic process?
The GO ID is GO:0006809.
What is S-nitrosylation and how does it relate to NO biosynthesis?
S-nitrosylation is the covalent attachment of NO to cysteine residues in proteins, a post-translational modification that can alter protein function and is linked to NO signaling.
Can CRISPR be used to study nitric oxide biosynthesis?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect the roles of NOS genes and other regulators of NO production.
Conclusion
Nitric oxide biosynthetic process (GO:0006809) is a central biological pathway with profound implications for human health and disease. The production of NO by NOS enzymes and its subsequent signaling and post-translational modifications influence cardiovascular, neuronal, and immune functions. Dysregulation of this process contributes to a wide range of pathologies, making it a key area of biomedical research. Advances in CRISPR-based models and screening technologies are enabling precise dissection of the molecular players and regulatory mechanisms, offering new opportunities for therapeutic intervention. EDITGENE's comprehensive services support researchers in creating tailored cell models to study NO biosynthesis and its roles in disease.
References
- 1. Robbins RA et al.. 1997. Nitric oxide.. Int J Biochem Cell Biol 29(6):857-60 PMID: 9304799
- 3. Broniowska KA et al.. 2014. β-Cell responses to nitric oxide.. Vitam Horm 95:299-322 PMID: 24559923
- 4. Levine AB et al.. 2012. Characterization of the role of nitric oxide and its clinical applications.. Cardiology 122(1):55-68 PMID: 22722323
- 5. Modun D et al.. 2014. Nitric oxide-related oxidative stress and redox status in health and disease.. Oxid Med Cell Longev 2014:129651 PMID: 25170388
- 6. Knowles RG. 1997. Nitric oxide biochemistry.. Biochem Soc Trans 25(3):895-901 PMID: 9388568
- 7. Gross SS et al.. 1995. Nitric oxide: pathophysiological mechanisms.. Annu Rev Physiol 57:737-69 PMID: 7539995
- 8. Horenberg AL et al.. 2019. S-nitrosylation of cytoskeletal proteins.. Cytoskeleton (Hoboken) 76(3):243-253 PMID: 30969482
